Iguana Healthcare Management as of March 31, 2017
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 69 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Medicines Company | 6.0 | $12M | 250k | 48.90 | |
Spdr S&p 500 Etf Tr option | 5.8 | $12M | 50k | 235.74 | |
Celgene Corporation | 5.5 | $11M | 90k | 124.43 | |
Shire | 5.3 | $11M | 61k | 174.24 | |
Amgen (AMGN) | 4.1 | $8.2M | 50k | 164.08 | |
Merck & Co (MRK) | 3.9 | $7.9M | 125k | 63.54 | |
Global Blood Therapeutics In | 3.6 | $7.4M | 200k | 36.85 | |
Aetna | 3.1 | $6.4M | 50k | 127.56 | |
Alexion Pharmaceuticals | 3.0 | $6.1M | 50k | 121.24 | |
Glaukos (GKOS) | 2.5 | $5.1M | 100k | 51.30 | |
Ultragenyx Pharmaceutical (RARE) | 2.5 | $5.1M | 75k | 67.79 | |
Dermira | 2.4 | $4.8M | 140k | 34.11 | |
Oncomed Pharmaceuticals | 2.2 | $4.5M | 490k | 9.21 | |
Merus N V (MRUS) | 2.1 | $4.3M | 175k | 24.39 | |
Allergan | 2.1 | $4.2M | 18k | 238.91 | |
K2m Group Holdings | 2.0 | $4.1M | 200k | 20.51 | |
Aerie Pharmaceuticals | 1.9 | $3.9M | 85k | 45.35 | |
Karyopharm Therapeutics (KPTI) | 1.8 | $3.5M | 275k | 12.84 | |
Clovis Oncology | 1.6 | $3.2M | 50k | 63.68 | |
Abbott Laboratories (ABT) | 1.5 | $3.1M | 70k | 44.41 | |
ALEXION PHARMACEUTICALS INC CMN Stock cmn | 1.5 | $3.0M | 25k | 121.24 | |
NuVasive | 1.5 | $3.0M | 40k | 74.68 | |
Walgreen Boots Alliance (WBA) | 1.4 | $2.9M | 35k | 83.06 | |
Supernus Pharmaceuticals (SUPN) | 1.4 | $2.8M | 90k | 31.30 | |
Biogen Idec (BIIB) | 1.4 | $2.7M | 10k | 273.40 | |
Esperion Therapeutics (ESPR) | 1.3 | $2.6M | 75k | 35.31 | |
Cardinal Health (CAH) | 1.2 | $2.4M | 30k | 81.57 | |
Immunomedics | 1.1 | $2.3M | 350k | 6.47 | |
Aclaris Therapeutics (ACRS) | 1.1 | $2.2M | 75k | 29.83 | |
Juno Therapeutics | 1.1 | $2.2M | 100k | 22.19 | |
Spectranetics Corporation | 1.1 | $2.2M | 75k | 29.12 | |
Tivity Health | 1.1 | $2.2M | 75k | 29.11 | |
Walgreens Boots Alliance | 1.0 | $2.1M | 25k | 83.04 | |
Allscripts Healthcare Solutions (MDRX) | 0.9 | $1.9M | 150k | 12.68 | |
LHC | 0.9 | $1.9M | 35k | 53.91 | |
Zimmer Holdings (ZBH) | 0.9 | $1.8M | 15k | 122.13 | |
Pacira Pharmaceuticals (PCRX) | 0.9 | $1.8M | 40k | 45.60 | |
Chemocentryx | 0.9 | $1.8M | 250k | 7.28 | |
Mazor Robotics Ltd. equities | 0.8 | $1.7M | 58k | 29.78 | |
Intersect Ent | 0.8 | $1.7M | 100k | 17.15 | |
Gilead Sciences (GILD) | 0.8 | $1.7M | 25k | 67.92 | |
AstraZeneca (AZN) | 0.8 | $1.6M | 50k | 31.14 | |
Alder Biopharmaceuticals | 0.8 | $1.6M | 75k | 20.80 | |
Achaogen | 0.8 | $1.5M | 60k | 25.23 | |
Anaptysbio Inc Common (ANAB) | 0.7 | $1.4M | 50k | 27.76 | |
Bristol-myers Squibb | 0.7 | $1.4M | 25k | 54.40 | |
Bioverativ Inc call | 0.7 | $1.4M | 25k | 54.48 | |
Epizyme | 0.6 | $1.3M | 75k | 17.15 | |
Cytomx Therapeutics (CTMX) | 0.6 | $1.3M | 75k | 17.27 | |
Impax Laboratories | 0.6 | $1.3M | 100k | 12.65 | |
Medicines | 0.6 | $1.2M | 25k | 48.92 | |
Diplomat Pharmacy | 0.6 | $1.2M | 75k | 15.95 | |
Pacific Biosciences of California (PACB) | 0.6 | $1.1M | 215k | 5.17 | |
Endologix | 0.5 | $1.1M | 150k | 7.24 | |
Ra Pharmaceuticals | 0.5 | $1.1M | 50k | 21.30 | |
Zynerba Pharmaceuticals | 0.5 | $1.0M | 50k | 20.10 | |
Immunomedics Inc Cmn Stk cmn | 0.5 | $971k | 150k | 6.47 | |
Mylan N V call | 0.5 | $975k | 25k | 39.00 | |
Theravance Biopharma (TBPH) | 0.5 | $921k | 25k | 36.84 | |
Scynexis | 0.4 | $828k | 300k | 2.76 | |
Minerva Neurosciences | 0.4 | $810k | 100k | 8.10 | |
Sangamo Biosciences (SGMO) | 0.4 | $780k | 150k | 5.20 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $551k | 75k | 7.35 | |
Applied Genetic Technol Corp C | 0.3 | $518k | 75k | 6.91 | |
Neovasc | 0.2 | $505k | 330k | 1.53 | |
Adma Biologics (ADMA) | 0.2 | $488k | 100k | 4.88 | |
Oncomed Pharmaceuticals | 0.2 | $461k | 50k | 9.22 | |
Obseva Sa | 0.1 | $260k | 25k | 10.40 | |
Tandem Diabetes Care | 0.1 | $120k | 100k | 1.20 |